AI assistant
Medtronic plc — Director's Dealing 2025
Jun 4, 2025
29841_dirs_2025-06-04_c5e68ce9-fb50-4f23-8a09-c3493254026d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2025-05-21
Reporting Person: KIIL HARRY SKIP (EVP & President Cardiovascular)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 33442 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $112.43 | 2031-12-10 | Ordinary Shares (34934) | Direct | |
| Stock Option (Right to Buy) | $93.08 | 2032-08-01 | Ordinary Shares (42174) | Direct | |
| Stock Option (Right to Buy) | $87.76 | 2033-07-31 | Ordinary Shares (38849) | Direct | |
| Stock Option (Right to Buy) | $80 | 2034-07-29 | Ordinary Shares (1540) | Direct | |
| Performance Share Unit | $ | Ordinary Shares (14146) | Direct | ||
| Performance Share Unit | $ | Ordinary Shares (14517) | Direct | ||
| Performance Share Unit | $ | Ordinary Shares (4806) | Direct | ||
| Performance Share Unit | $ | Ordinary Shares (15378) | Direct |
Footnotes
F1: Includes 2,200 restricted stock units that vested on December 6, 2024; 5,658 restricted stock units that vest on August 1, 2025; 2,200 restricted stock units that vest on December 6, 2025; 5,807 restricted stock units that vest of July 31, 2026; 2,199 restricted stock units that vest on December 6, 2026; and 15,378 restricted stock units that vest on July 29, 2027.
F2: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F3: The performance share units vest on August 1, 2025.
F4: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,146 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F5: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6: The performance share units vest on April 26, 2026.
F7: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,517 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F8: The performance share units vest on December 6, 2026.
F9: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 4,806 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F10: The performance share units vest on April 30, 2027.
F11: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.